Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 183 results found. Search for [ Oxford corona vaccine ]

Results 1 to 21 of 183
Ashutosh Kumar
April 19, 2021
The government will make pre-payment to both Serum Institute of India and Bharat Biotech for the vaccine supply. \"This will serve as an incentive to the two vaccine suppliers,\" said a source


BusinessToday.In
New Delhi, April 19, 2021
A modified version of AstraZeneca's COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday; Former prime minister Manmohan Singh on Sunday wrote to Prime Minister Narendra Modi on the COVID-19 crisis, stressing that ramping up vaccination was the key to battling the pandemic; China will expand digital yuan experiments to more cities, but there is no specific timetable for its official rollout. China is one of the frontrunners in the global race to launch central bank digital currencies to modernise financial systems. Watch this and more on News Blast.Also Read: Oxford University to reinfect recovered Covid-19 patients to develop better vaccines


BusinessToday.In
April 14, 2021
Coronavirus vaccination: After taking the first shot, the vaccine beneficiary will receive a message on his/her registered mobile number about the link to download the vaccination certificate


BusinessToday.In
April 14, 2021
A total of 82,339 patients were discharged in the past 24 hours. As of April 14, India's total case tally stands at 1.38 crore; total recoveries 1.2 crore; active cases 13.6 lakh; and 1.72 lakh patients have died


Rashi Bisaria
New Delhi, April 9, 2021
Australia, Philippines, African Union ban AstraZeneca's COVID-19 shotAustralia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world. The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concerns and supply problems since Phase III tria...


BusinessToday.In
New Delhi, April 7, 2021
International Monetary Fund (IMF) on Tuesday raised its growth forecast for Indian economy by 100 basis points to 12.5 per cent for fiscal year 2021-22; Billionaire Gautam Adani's ports-to-energy conglomerate has become India's third group to cross $100 billion in market capitalisation with shares of four of its six listed companies soaring to an all-time high; President Joe Biden has announced that he's bumping up his deadline by two weeks for states to make all adults in the US eligible for coronavirus vaccines. This and more on News Blast.Also Read: IT skills in top demand! Jobs aplenty for professionals with these expertise


Rashi Bisaria
New Delhi, April 7, 2021
Oxford-AstraZeneca pauses COVID-19 vaccine trial in children The University of Oxford said on Tuesday it had paused a small UK trial testing the Covid-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits for more data on rare blood clotting issues in adults who received the shot. The trial disruption is the latest blow to the vaccine, once hailed as a milestone in the fight against the pandemic IMF raises India's growth forecast for FY22 to 12.5% Internat...


PTI
February 17, 2021
The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


BusinessToday.In
New Delhi, February 6, 2021
The Reserve Bank of India projected Indian economy to grow as much as 26.2 per cent during the first half of the upcoming financial year; Drugmaker AstraZeneca PLC said on Friday it had applied for approval in Japan of its COVID-19 vaccine; Ministry of Housing and Urban Affairs (MoHUA) has signed a memorandum of understanding (MoU) with Zomato for empowering street food vendors. Watch this and more on News Blast.Also Read: Oxford-Astrazeneca COVID-19 vaccine effective against mutant UK variant


Rashi Bisaria
New Delhi, February 6, 2021
Covid-19 vaccine: AstraZeneca applies for approval in JapanDrugmaker AstraZeneca PLC said on Friday it had applied for approval in Japan of its COVID-19 vaccine, making it the second pharmaceutical firm to do so after Pfizer Inc. The Japanese government in December signed a contract to procure 120 million doses of the AstraZeneca vaccine, enough for 60 million people. Aviation sector showing positive signs but still in eye of storm: Airbus India presidentThe Indian aviation sector is showi...


PB Jayakumar
January 26, 2021
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months


PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet


PTI
January 20, 2021
It is learnt that 1,50,000 doses of Covisheild vaccine, manufactured by the Serum Institute of India (SII), were sent to Bhutan and 1,00,000 doses reached Maldives as part of India's grant assistance


BusinessToday.In
New Delhi, January 12, 2021
The first consignment of Covishield vaccine, having rolled out of the Serum Institute of India in Pune, reached Delhi, Chennai and Ahmedabad. The nation is getting ready for a massive pan-India inoculation drive against COVID-19, starting January 16. Four airlines were authorised to operate nine flights, to transport 56.5 lakh doses of the vaccine from Pune to 13 cities across the country. Three crore healthcare and frontline workers will be vaccinated in the first phase of the drive. Watch the video for more.Also Read: Four more COVID-19 vaccines on cards in India, check prices here


BusinessToday.In
January 5, 2021
Without naming Serum Institute CEO Adar Poonawalla, who had termed vaccines other than that of Pfizer, Moderna and Oxford-AstraZeneca as 'just like water', Krishna Ella said, 'We do 200 per cent honest clinical trials and yet we receive backlash'


BusinessToday.In
January 4, 2021
Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals


BusinessToday.In
January 4, 2021
Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks


BusinessToday.In
January 4, 2021
Coronavirus vaccine in India: In an interview, Serum Institute CEO Adar Poonawalla said that the company has also been barred from selling the vaccine on the private market


BusinessToday.In
January 4, 2021
Union Health Minister Dr Harsh Vardhan slammed senior Congress party leaders Shashi Tharoor and Jairam Ramesh, and Samajwadi Party leader Akhilesh Yadav for politicising the 'critical issue'


PAGES 1 OF 10  12345